179 related articles for article (PubMed ID: 5973024)
1. Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin.
Ostrowski L
Pol Med J; 1966; 5(6):1197-214. PubMed ID: 5973024
[No Abstract] [Full Text] [Related]
2. [Effect of cysteine and hemolyzed erythrocytes on the properties of clotted fibrin].
Ostrowski L
Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1964; 10():118-35. PubMed ID: 4955710
[No Abstract] [Full Text] [Related]
3. On the physical properties of fibrin clots during desmofibrinogenesis.
Buluk K; Zuch A; Olbromski J
Arch Immunol Ther Exp (Warsz); 1968; 16(1):12-23. PubMed ID: 5651517
[No Abstract] [Full Text] [Related]
4. [Studies on the changes in blood coagulation factors through parenteral administration of cobalt(II) compounds in rabbits].
Wohllebe W; Taube C; Fiedler H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(3):315-21. PubMed ID: 4176081
[No Abstract] [Full Text] [Related]
5. Thrombelastographic patterns of ancrod and thrombin fibrin formation and dissolution.
Caprini JA; Kwaan HC; Zuckerman L; Verduin R
Thromb Res; 1974 Feb; 4(2):199-217. PubMed ID: 4275415
[No Abstract] [Full Text] [Related]
6. The action of Arvin on Fibrin Stabilizing Factor (factor 13).
Barlow GH; Holleman WH; Lorand L
Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):39-42. PubMed ID: 5535658
[No Abstract] [Full Text] [Related]
7. Effects of Bothrops jararaca venom on fibrin formation in vitro.
Ponari O; Civardi E
Arzneimittelforschung; 1973 Jan; 23(1):94-8. PubMed ID: 4740702
[No Abstract] [Full Text] [Related]
8. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
Nielsen VG
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
[TBL] [Abstract][Full Text] [Related]
9. New method to prepare autologous fibrin glue on demand.
Alston SM; Solen KA; Broderick AH; Sukavaneshvar S; Mohammad SF
Transl Res; 2007 Apr; 149(4):187-95. PubMed ID: 17383592
[TBL] [Abstract][Full Text] [Related]
10. [Injections of tissue extracts and autologous hemolysates in the dog. Effects on the factors of hemostasis].
Dosne AM; Josso F; Soulier JP; Lavergne JM; Malmejac J
Nouv Rev Fr Hematol; 1968; 8(1):21-34. PubMed ID: 4232147
[No Abstract] [Full Text] [Related]
11. Retraction and firmness of the fibrin clot.
Farská I
Physiol Bohemoslov; 1966; 15(1):79-87. PubMed ID: 4222574
[No Abstract] [Full Text] [Related]
12. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
Soria J; Soria C; Samama M; Poirot E; Kling C
Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617
[No Abstract] [Full Text] [Related]
13. Quantitation of the coagulation inhibition in vivo due to breakdown products of fibrin.
Mitchell PS; Beller FK
Thromb Diath Haemorrh; 1970 Jun; 23(3):477-85. PubMed ID: 4989113
[No Abstract] [Full Text] [Related]
14. [Fibrinogen derivatives appearing in calf plasma after the action of thrombin and endotoxin].
Benabid Y; Laurent M; Concord E; Suscillon M
Pathol Biol (Paris); 1973 Nov; 21():Suppl:24-30. PubMed ID: 4587012
[No Abstract] [Full Text] [Related]
15. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
[No Abstract] [Full Text] [Related]
16. [Functional state of the anticoagulation system during intravenous administration of fibrin monomer].
Kudriashov BA; Molchanova LV; Kalishevskaia TM; Bazaz'ian GG; Pastorova VE; Sytina NP
Vopr Med Khim; 1969; 15(5):483-6. PubMed ID: 5368085
[No Abstract] [Full Text] [Related]
17. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
Marguerie G; Hudry G; Hollard D
Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
[No Abstract] [Full Text] [Related]
18. Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.
Gurbel PA; Bliden KP; Guyer K; Aggarwal N; Tantry US
Thromb Res; 2007; 119(5):563-70. PubMed ID: 16806409
[TBL] [Abstract][Full Text] [Related]
19. PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.
NUSSBAUM M; MORSE BS
Blood; 1964 May; 23():669-78. PubMed ID: 14142505
[No Abstract] [Full Text] [Related]
20. A simple gravimetric method for estimation of plasma fibrinogen.
Saxena KK; Srivastava RK; Kulshrestha VK; Prasad DN
Indian J Physiol Pharmacol; 1979; 23(2):137-9. PubMed ID: 489096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
